Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Grunenthal Gmbh
Grunenthal Gmbh_20100114

Grunenthal Gmbh patents

Recent patent applications related to Grunenthal Gmbh. Grunenthal Gmbh is listed as an Agent/Assignee. Note: Grunenthal Gmbh may have other listings under different names/spellings. We're not affiliated with Grunenthal Gmbh, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Grunenthal Gmbh-related inventors

Date Grunenthal Gmbh patents (updated weekly) - BOOKMARK this page
10/27/16Tamper-resistant fixed dose combination providing fast release of two drugs from different particles
10/27/16Tamper-resistant dosage form with immediate release and resistance against solvent extraction
10/06/16Fluoromethyl-substituted pyrrole carboxamides iii
09/15/16Preparation of a powdery pharmaceutical composition by means of cryo-milling
04/21/16Tamper resistant dosage form comprising inorganic salt
01/28/16Novel 2,5-substituted pyrimidines
12/25/14Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
07/31/14Substituted 6-amino-nicotinamides as kcnq2/3 modulators
07/10/14Oxidation-stabilized tamper-resistant dosage form
06/05/14Process for the production of an abuse-proofed solid dosage form
04/03/14Abuse-proofed dosage form
03/27/14Dosage form that is safeguarded from abuse
08/29/13Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
08/29/13Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
08/15/13Tamper resistant dosage form comprising inorganic salt
08/01/13Abuse-proofed dosage form
07/04/13Abuse-proofed dosage form
06/06/13Method and device for supplying liquids to analysis units and liquid handling systems
01/31/13Tamper-resistant tablet providing immediate drug release
01/31/13Tamper-resistant tablet providing immediate drug release
12/06/12Abuse-proofed dosage form
10/11/12Substituted 6-amino-nicotinamides as kcnq2/3 modulators
08/30/12Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
08/09/12Substituted 4-aminocyclohexane derivatives
07/19/12Substituted nicotinamides as kcnq2/3 modulators
05/31/12Abuse-proofed dosage form
05/31/12Oxidation-stabilized tamper-resistant dosage form
04/26/12Substituted 6-amino-nicotinamides as kcnq2/3 modulators
03/15/12Tamper resistant dosage form comprising an anionic polymer
03/08/12Pharmaceutical salts
03/01/12Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
03/01/12Substituted quinoline-3-carboxamides as kcnq2/3 modulators
03/01/12Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
02/23/12Novel therapeutic compounds
02/02/12Oral contraception with trimegestone
01/19/12Novel gastro-retentive dosage forms
12/15/11Novel therapeutic compounds
08/04/11Preparation of a powdery pharmaceutical composition by means of an extruder
07/14/11Dosace form for hormonal contraceptive
02/17/11Hot-melt extruded pharmaceutical dosage form
01/27/11Tamper-resistant dosage form for oxidation-sensitive opioids
01/20/11Mixed orl1/mu-agonists for the treatment of pain
10/14/10Abuse-proofed dosage form
09/16/10Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators
09/16/10Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
09/16/10Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
09/16/10Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators
07/22/10Star distributor
06/17/10Crush resistant delayed-release dosage forms
06/17/10Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators
06/03/10Method for the production of a form of administration of a medicament
01/14/10Substituted heteroaryl derivatives
12/24/093-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases
12/24/09Process for selectively synthesising 3 alpha-hydroxychlormadinone acetate
12/17/09Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases
10/22/09Estra-1,3,5(10)-triene derivatives for contraception
10/15/09Pharmaceutical salts
10/01/09Spiro(5.5)undecane derivatives
10/01/09Substituted 4-aminocyclohexane derivatives
10/01/09Substituted spirocyclic cyclohexane derivatives
10/01/09(hetero)aryl cyclohexane derivatives
10/01/09Substituted cyclohexyldiamines
08/27/09Substituted 4-aminocyclohexane derivatives
08/27/09Substituted indole derivatives
08/13/09Pharmaceutical dosage form
Patent Packs
07/16/09Substituted bis(hetero)aromatic n--ethylpropiolamides and use thereof for production of medicaments
07/09/09Substituted thiazoles and their use for producing drugs
06/18/09Spirocyclic azaindole derivatives
04/09/0919-nor-progesterone for contraception
03/19/09Substituted propiolic acid amides and their use for producing drugs
01/14/10Substituted heteroaryl derivatives

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Grunenthal Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Grunenthal Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by